tiprankstipranks
Sage Therapeutics resumed with an Underperform at BofA
PremiumThe FlySage Therapeutics resumed with an Underperform at BofA
14d ago
Early notable gainers among liquid option names on March 10th
Premium
The Fly
Early notable gainers among liquid option names on March 10th
14d ago
Unusually active option classes on open March 10th
Premium
The Fly
Unusually active option classes on open March 10th
14d ago
Biogen, Stoke Therapeutics announce zorevunersen commercialization agreement
PremiumThe FlyBiogen, Stoke Therapeutics announce zorevunersen commercialization agreement
1M ago
Biogen price target lowered to $135 from $138 at Piper Sandler
Premium
The Fly
Biogen price target lowered to $135 from $138 at Piper Sandler
1M ago
QQQ ETF News, 2/17/2025
Premium
Market News
QQQ ETF News, 2/17/2025
1M ago
Biogen price target lowered to $225 from $231 at RBC Capital
PremiumThe FlyBiogen price target lowered to $225 from $231 at RBC Capital
1M ago
Biogen price target lowered to $135 from $166 at Wedbush
Premium
The Fly
Biogen price target lowered to $135 from $166 at Wedbush
1M ago
Biogen price target lowered to $200 from $275 at TD Cowen
Premium
The Fly
Biogen price target lowered to $200 from $275 at TD Cowen
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100